| scholarly article | Q13442814 |
| P2093 | author name string | Georg Becher | |
| Cathrine Thomsen | |||
| Line S Haug | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2131-2136 | |
| P577 | publication date | 2009-03-01 | |
| P1433 | published in | Environmental Science & Technology | Q689027 |
| P1476 | title | Time trends and the influence of age and gender on serum concentrations of perfluorinated compounds in archived human samples | |
| P478 | volume | 43 |
| Q93336503 | A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects |
| Q43746970 | A temporal trend study (1972–2008) of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in pooled human milk samples from Stockholm, Sweden |
| Q50944825 | An automated high-throughput SPE micro-elution method for perfluoroalkyl substances in human serum. |
| Q58080051 | Associations between longitudinal serum perfluoroalkyl substance (PFAS) levels and measures of thyroid hormone, kidney function, and body mass index in the Fernald Community Cohort |
| Q40712408 | Brief Report: Plasma Concentrations of Perfluorooctane Sulfonamide and Time-to-pregnancy Among Primiparous Women |
| Q42797195 | Changes in Concentrations of Perfluorinated Compounds, Polybrominated Diphenyl Ethers, and Polychlorinated Biphenyls in Norwegian Breast-Milk during Twelve Months of Lactation |
| Q34549978 | Chronic exposure to perfluorooctane sulfonate induces behavior defects and neurotoxicity through oxidative damages, in vivo and in vitro |
| Q42848935 | Concentrations of perfluorinated compounds in human blood from twelve cities in China |
| Q35544436 | Concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) and their associations with human semen quality measurements |
| Q46198292 | Determinants of maternal and fetal exposure and temporal trends of perfluorinated compounds |
| Q36707568 | Determinants of plasma concentrations of perfluoroalkyl substances in pregnant Norwegian women. |
| Q51008936 | Determination of perfluorinated compounds in human plasma and serum Standard Reference Materials using independent analytical methods. |
| Q90609270 | Dietary Habits Related to Food Packaging and Population Exposure to PFASs |
| Q33606598 | Dietary predictors and plasma concentrations of perfluorinated compounds in a coastal population from northern Norway |
| Q46785218 | Dosimetric anchoring of in vivo and in vitro studies for perfluorooctanoate and perfluorooctanesulfonate |
| Q24634181 | Exploring indirect sources of human exposure to perfluoroalkyl carboxylates (PFCAs): evaluating uptake, elimination, and biotransformation of polyfluoroalkyl phosphate esters (PAPs) in the rat |
| Q39626742 | Exposure of children aged 0-7 years to perfluorinated compounds in Foshan, China |
| Q35156203 | Fetal exposure to perfluorinated compounds and attention deficit hyperactivity disorder in childhood |
| Q38211816 | Human biomonitoring of emerging pollutants through non-invasive matrices: state of the art and future potential |
| Q37784718 | Isomer Profiling of Perfluorinated Substances as a Tool for Source Tracking: A Review of Early Findings and Future Applications |
| Q36159527 | Level and temporal trend of perfluoroalkyl acids in Greenlandic Inuit |
| Q36095017 | Longitudinal measures of perfluoroalkyl substances (PFAS) in serum of Gullah African Americans in South Carolina: 2003-2013. |
| Q37465246 | Maternal concentrations of persistent organochlorine pollutants and the risk of asthma in offspring: results from a prospective cohort with 20 years of follow-up |
| Q37997949 | Neurotoxic effects of perfluoroalkylated compounds: mechanisms of action and environmental relevance |
| Q41680740 | Oral repeated-dose systemic and reproductive toxicity of 6:2 fluorotelomer alcohol in mice |
| Q27342808 | PFOS induces behavioral alterations, including spontaneous hyperactivity that is corrected by dexamfetamine in zebrafish larvae |
| Q91532654 | Per- and polyfluoroalkyl substances in Northern California cats: Temporal comparison and a possible link to cat hyperthyroidism |
| Q47833635 | Per- and polyfluoroalkyl substances in sera from children 3 to 11 years of age participating in the National Health and Nutrition Examination Survey 2013-2014. |
| Q35977905 | Perfluorinated alkyl acids in the plasma of South African crocodiles (Crocodylus niloticus). |
| Q37668109 | Perfluorinated alkyl substances in serum of the southern Chinese general population and potential impact on thyroid hormones |
| Q35748439 | Perfluorinated compounds and subfecundity in pregnant women. |
| Q37408761 | Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study |
| Q35562877 | Perfluoroalkyl substances and ovarian hormone concentrations in naturally cycling women |
| Q37671906 | Perfluoroalkyl substances during pregnancy and validated preeclampsia among nulliparous women in the Norwegian Mother and Child Cohort Study |
| Q40251746 | Perfluoroalkyl substances with isomer analysis in umbilical cord serum in China. |
| Q36456189 | Perfluorooctane Sulfonate Concentrations in Amniotic Fluid, Biomarkers of Fetal Leydig Cell Function, and Cryptorchidism and Hypospadias in Danish Boys (1980-1996). |
| Q59291211 | Perfluorooctanoic acid (PFOA) — main concerns and regulatory developments in Europe from an environmental point of view |
| Q37515010 | Persistent organic pollutants and male reproductive health |
| Q36064764 | Phthalates and perfluorooctanesulfonic acid in human amniotic fluid: temporal trends and timing of amniocentesis in pregnancy |
| Q47106665 | Plasma Perfluoroalkyl and Polyfluoroalkyl Substances Concentration and Menstrual Cycle Characteristics in Preconception Women |
| Q35920263 | Polyfluoroalkyl compounds in Texas children from birth through 12 years of age. |
| Q42277537 | Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood |
| Q35941792 | Prenatal exposure to perfluorooctanoate and risk of overweight at 20 years of age: a prospective cohort study |
| Q35941864 | Relationships of perfluorooctanoate and perfluorooctane sulfonate serum concentrations between mother-child pairs in a population with perfluorooctanoate exposure from drinking water |
| Q28397823 | Reliability of perfluoroalkyl substances in plasma of 100 women in two consecutive pregnancies |
| Q50668970 | Repeated dose and reproductive/developmental toxicity of perfluorododecanoic acid in rats. |
| Q62086877 | Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food |
| Q45376606 | Serum concentrations of perfluorinated alkyl acids and their associations with diet and personal characteristics among Swedish adults |
| Q56795458 | Shifting Global Exposures to Poly- and Perfluoroalkyl Substances (PFASs) Evident in Longitudinal Birth Cohorts from a Seafood-Consuming Population |
| Q90455813 | Socio-Economic Status and Health: Evaluation of Human Biomonitored Chemical Exposure to Per- and Polyfluorinated Substances across Status |
| Q90697809 | Temporal Trends (1981-2013) of Per- and Polyfluoroalkyl Substances and Total Fluorine in Baltic cod (Gadus morhua) |
| Q90088329 | Toxicokinetics of 8:2 fluorotelomer alcohol (8:2-FTOH) in male and female Hsd:Sprague Dawley SD rats after intravenous and gavage administration |
| Q43536002 | Trends in human concentrations of endocrine disruptors: possible reasons and consequences |
| Q62750562 | Trends, analytical methods and precision in the determination of perfluoroalkyl acids in human milk |
Search more.